Medical education that transforms your clinical practice

Physician with a PhD in Sciences from the Federal University of São Paulo and a habilitation (livre-docência) in Cardiology from the Escola Paulista de Medicina. He completed a postdoctoral fellowship, a Cardiology fellowship and a Master of Health Sciences in Clinical Research at Duke University. He is a professor in the Department of Medicine, Division of Cardiology, at Duke University in the United States, and a member of the Duke Clinical Research Institute. Faculty Founder of BCRI. Fellow of the American Heart Association, the American College of Cardiology, the American College of Physicians and the European Society of Cardiology.

Physician from the Federal University of São Paulo (UNIFESP), with a master’s degree, a PhD and a habilitation (livre-docência) in Nephrology from the same institution, and a postdoctoral fellowship at Tufts University School of Medicine. Management training at the Harvard Business School Advanced Management Program. Associate Professor at UNIFESP and Adjunct Assistant Professor of Medicine at Tufts. At Hospital Israelita Albert Einstein, he was Director of Medical Practice, Medical Director, Superintendent Director, Technical Director and COO of the private hospitals. He is now VP – Physician Enterprise at TribeMD ES, mentoring medical talent and leading the relationship with the medical staff.

Psychiatrist with a master’s degree in Clinical Psychiatry from the Federal University of São Paulo (UNIFESP), registered under CRM-SP 133.853 and RQE 38.659. Management training at XBA – Xponential Business Administration. He is now CEO of MD Life, which brings together the TribeMD, BCRI and BIPP ecosystem. At TribeMD/Med.IQ, he was Chief Medical Officer (CMO) and Chief Artificial Intelligence Officer (CAIO). At Grupo BIPP, he was CEO and is now chairman. He is also a speaker on medical management and the use of artificial intelligence in healthcare.

PhD in Cardiology from the Federal University of São Paulo, with a Master of Health Sciences in Clinical Research from Duke University. Physician researcher at the Research Institute of Hospital do Coração and at the Brazilian Clinical Research Institute (BCRI). He is a director of the Brazilian Society of Internal Medicine and a member of the Guidelines Standards Council of the Brazilian Society of Cardiology. A Fellow of the American College of Physicians, the American College of Cardiology and the European Society of Cardiology, he sits on the executive committee of the Global Heart Attack Treatment Initiative (GHATI). He is now Academic Chief Medical Officer of the Med.IQ group.

Cardiologist from the University of São Paulo (USP), with residency and specialization in acute coronary disease and myocardial infarction at the Heart Institute of Hospital das Clínicas, FMUSP (InCor). PhD from USP, with a research period at Brigham and Women's Hospital, Harvard. Attending physician at InCor and researcher in acute coronary syndromes, antiplatelet agents and atherosclerosis, with more than 60 international publications. He is now Medical Director of BCRI, where he coordinates multicenter studies, randomized clinical trials and real-world research.

Obstetrician and gynecologist from the University of São Paulo (USP), with a master’s degree in Medical Sciences from the same institution and a fellowship in Clinical Research at Harvard Medical School. MBA in Business Management from Insper. She built solid experience in medical leadership roles in the Brazilian and multinational pharmaceutical industry, at companies such as Aché, AstraZeneca, Sanofi, Boehringer-Ingelheim, Danone and Procter & Gamble. She is now LATAM Medical Director of Medical Affairs Operations at Med.IQ.

Physician from the State University of Londrina and psychiatrist trained at Santa Casa de São Paulo. He is one of the authors of the Brazilian treatment guidelines for Panic Disorder, Social Anxiety Disorder and Generalized Anxiety Disorder, and one of the coordinators of the Reference Group for Anxiety and Mood Disorders (GRETAH) at FCMSCSP. He currently studies the interface between physiological markers and psychiatric disorders and the use of artificial intelligence techniques in medical applications.